+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Nipro Corp (8086) - Financial and Strategic SWOT Analysis Review

1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Nipro Corp (8086) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by the publisher to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company's operations and business divisions.
  • Corporate strategy - Analyst's summarization of the company's business strategy.
  • SWOT Analysis - A detailed analysis of the company's strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives' employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.


Nipro Corp (Nipro) develops, manufactures and commercializes pharmaceuticals, medical equipment and functional materials including glass, rubber and plastic products. The company's products include renal products, interventional and anaesthesiology products, injection and infusion products, cardiopulmonary products, double bags, pre-filled syringes, and half-type kits among others. It offers contract manufacturing services of development, manufacturing of drug formulations, inspection, packaging, logistics and distribution services. Nipro also provides glass molding vials, ampoules, syringes, and cartridges; glass tubes for pharmaceuticals; glass-forming machinery; other parts of pharmaceutical packaging including rubber plugs; and glass bulbs for vacuum flasks. The company has sales offices in North America, South America, Europe, Asia and Africa. Nipro is headquartered in Settsu, Osaka, Japan.

Nipro Corp Key Recent Developments

  • Feb 21, 2023: Prevas UX/UI-expertise helps Nipro
  • Jun 28, 2022: Nipro Notice of Resolutions at the 69th Annual General Meeting of Shareholders

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • Nipro Corp - Key Facts
  • Nipro Corp - Key Employees
  • Nipro Corp - Major Products and Services
  • Nipro Corp - History
  • Nipro Corp - Company Statement
  • Nipro Corp - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Joint Venture
Section 2 - Company Analysis
  • Company Overview
  • Nipro Corp - Business Description
  • Business Segment: Medical-Related
  • Overview
  • Performance
  • Business Segment: Other
  • Overview
  • Performance
  • Business Segment: Pharma Packaging
  • Overview
  • Performance
  • Business Segment: Pharmaceutical-Related
  • Overview
  • Performance
  • Geographical Segment: America
  • Performance
  • Geographical Segment: Asia
  • Performance
  • Geographical Segment: Europe
  • Performance
  • Geographical Segment: Japan
  • Performance
  • R&D Overview
  • Nipro Corp - Corporate Strategy
  • Nipro Corp - SWOT Analysis
  • SWOT Analysis - Overview
  • Nipro Corp - Strengths
  • Nipro Corp - Weaknesses
  • Nipro Corp - Opportunities
  • Nipro Corp - Threats
  • Nipro Corp - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Nipro Corp, Medical Equipment, Deals By Year, 2017 to YTD 2023
  • Nipro Corp, Medical Equipment, Deals By Type, 2017 to YTD 2023
  • Nipro Corp, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Feb 21, 2023: Prevas UX/UI-expertise helps Nipro
  • Jun 28, 2022: Nipro Notice of Resolutions at the 69th Annual General Meeting of Shareholders
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Publisher
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Nipro Corp, Key Facts
  • Nipro Corp, Key Employees
  • Nipro Corp, Major Products and Services
  • Nipro Corp, History
  • Nipro Corp, Other Locations
  • Nipro Corp, Subsidiaries
  • Nipro Corp, Joint Venture
  • Nipro Corp, Key Competitors
  • Nipro Corp, Ratios based on current share price
  • Nipro Corp, Annual Ratios
  • Nipro Corp, Interim Ratios
  • Nipro Corp, Medical Equipment, Deals By Year, 2017 to YTD 2023
  • Nipro Corp, Medical Equipment, Deals By Type, 2017 to YTD 2023
  • Nipro Corp, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Nipro Corp, Performance Chart (2019 - 2023)
  • Nipro Corp, Ratio Charts
  • Nipro Corp, Medical Equipment, Deals By Year, 2017 to YTD 2023
  • Nipro Corp, Medical Equipment, Deals by Type, 2017 to YTD 2023



Companies Mentioned

A selection of companies mentioned in this report includes:

  • Mitsubishi Tanabe Pharma Corp
  • Kyowa Kirin Co Ltd
  • IMI Co Ltd
  • Chugai Pharmaceutical Co Ltd
  • Asahi Kasei Medical Co Ltd
  • Taiho Pharmaceutical Co Ltd
  • Fresenius SE & Co KGaA
  • Terumo Corp
  • JMDC Inc
  • Getinge Holding BV & Co KG